---
document_datetime: 2023-09-21 17:18:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/qtern-epar-all-authorised-presentations_en.pdf
document_name: qtern-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8909086
conversion_datetime: 2025-12-19 03:05:19.263303
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength     | Pharmaceutical Form   | Route of Administration   | Immediate Packaging      | Pack size                                   |
|------------------|-------------------|--------------|-----------------------|---------------------------|--------------------------|---------------------------------------------|
| EU/1/16/1108/001 | Qtern             | 5 mg / 10 mg | Film-coated tablet    | Oral use                  | blister (PA/Alu/PVC-Alu) | 14 film-coated tablets in calendar blisters |
| EU/1/16/1108/002 | Qtern             | 5 mg / 10 mg | Film-coated tablet    | Oral use                  | blister (PA/Alu/PVC-Alu) | 28 film-coated tablets in calendar blisters |
| EU/1/16/1108/003 | Qtern             | 5 mg / 10 mg | Film-coated tablet    | Oral use                  | blister (PA/Alu/PVC-Alu) | 98 film-coated tablets in calendar blisters |
| EU/1/16/1108/004 | Qtern             | 5 mg / 10 mg | Film-coated tablet    | Oral use                  | blister (PA/Alu/PVC-Alu) | 30 film-coated tablets in blisters          |